American Oncology Network Inc (AONC)
3.78
-0.07
(-1.82%)
USD |
NASDAQ |
May 02, 16:00
3.93
+0.15
(+3.97%)
After-Hours: 20:00
American Oncology Network Enterprise Value: 289.25M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 289.25M |
| May 01, 2024 | 289.99M |
| April 30, 2024 | 289.67M |
| April 29, 2024 | 295.61M |
| April 26, 2024 | 291.63M |
| April 25, 2024 | 290.41M |
| April 24, 2024 | 297.94M |
| April 23, 2024 | 300.07M |
| April 22, 2024 | 300.28M |
| April 19, 2024 | 300.91M |
| April 18, 2024 | 297.10M |
| April 17, 2024 | 305.69M |
| April 16, 2024 | 306.32M |
| April 15, 2024 | 303.46M |
| April 12, 2024 | 308.13M |
| April 11, 2024 | 307.28M |
| April 10, 2024 | 305.26M |
| April 09, 2024 | 307.70M |
| April 08, 2024 | 306.96M |
| April 05, 2024 | 307.28M |
| April 04, 2024 | 307.28M |
| April 03, 2024 | 307.28M |
| April 02, 2024 | 309.08M |
| April 01, 2024 | 308.98M |
| March 28, 2024 | 307.38M |
| Date | Value |
|---|---|
| March 27, 2024 | 311.73M |
| March 26, 2024 | 312.48M |
| March 25, 2024 | 311.73M |
| March 22, 2024 | 307.69M |
| March 21, 2024 | 307.69M |
| March 20, 2024 | 303.40M |
| March 19, 2024 | 303.31M |
| March 18, 2024 | 301.60M |
| March 15, 2024 | 303.40M |
| March 14, 2024 | 302.21M |
| March 13, 2024 | 303.79M |
| March 12, 2024 | 302.36M |
| March 11, 2024 | 303.31M |
| March 08, 2024 | 303.40M |
| March 07, 2024 | 306.15M |
| March 06, 2024 | 306.26M |
| March 05, 2024 | 306.36M |
| March 04, 2024 | 308.47M |
| March 01, 2024 | 306.26M |
| February 29, 2024 | 305.97M |
| February 28, 2024 | 303.98M |
| February 27, 2024 | 304.55M |
| February 26, 2024 | 306.58M |
| February 23, 2024 | 303.40M |
| February 22, 2024 | 303.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
132.18M
Minimum
Sep 29 2023
525.08M
Maximum
Sep 30 2023
377.84M
Average
307.50M
Median
Feb 20 2024
Enterprise Value Benchmarks
| Encompass Health Corp | 11.59B |
| Pediatrix Medical Group Inc | 1.213B |
| US Physical Therapy Inc | 1.732B |
| US Neurosurgical Holding Inc | 9.114M |
| The Oncology Institute Inc | 89.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.75M |
| Revenue (Quarterly) | 324.18M |
| Total Expenses (Quarterly) | 343.44M |
| EPS Diluted (Quarterly) | -0.75 |
| Gross Profit Margin (Quarterly) | 2.66% |
| Profit Margin (Quarterly) | -1.16% |
| Earnings Yield | -28.79% |
| Normalized Earnings Yield | 107.09 |